BE1003255A5 - Acides (rs)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofurannyl)-acetiques et acides 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzo-furannyl)-acetiques et leurs esters mucoregulateurs et anti-ischemiques et procede pour les preparer. - Google Patents

Acides (rs)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofurannyl)-acetiques et acides 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzo-furannyl)-acetiques et leurs esters mucoregulateurs et anti-ischemiques et procede pour les preparer. Download PDF

Info

Publication number
BE1003255A5
BE1003255A5 BE8900822A BE8900822A BE1003255A5 BE 1003255 A5 BE1003255 A5 BE 1003255A5 BE 8900822 A BE8900822 A BE 8900822A BE 8900822 A BE8900822 A BE 8900822A BE 1003255 A5 BE1003255 A5 BE 1003255A5
Authority
BE
Belgium
Prior art keywords
dihydro
acids
acetics
trimethylbenzofurannyl
acyloxy
Prior art date
Application number
BE8900822A
Other languages
English (en)
Original Assignee
Foscama Biomed Chim Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foscama Biomed Chim Farma filed Critical Foscama Biomed Chim Farma
Application granted granted Critical
Publication of BE1003255A5 publication Critical patent/BE1003255A5/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Les acides (RS)-2-(2,3-dihydro-5-hydroxy-4,6,7 triméthylbenzofurannyl) acétiques et acides 2-(2,3-dihydro-5-acyloxy-4,6,7 triméthylbenzofurannyl) acétiques, de même que leurs esters, sont des substances antioxydantes convenant comme agents thérapeutiques pour le traitement de l'emphyzème pulmonaire et des processus inflammatoires des muqueuses de l'appareil respiratoire, de même que pour le traitement des séquelles de l'infarctus cérébral ou cardiaque. Ils sont préférés comme mucolytiques.
BE8900822A 1988-08-01 1989-08-01 Acides (rs)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofurannyl)-acetiques et acides 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzo-furannyl)-acetiques et leurs esters mucoregulateurs et anti-ischemiques et procede pour les preparer. BE1003255A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821603A IT1229482B (it) 1988-08-01 1988-08-01 Acidi (rs) 2 (2,3 diidro 5 idrossi 4,6,7 trimetilbenzofuranil) acetico e 2 (2,3 diidro 5 acilossi 4,6,7 trimetilbenzofuranil) acetici e loro esteri, utili come farmaci mucoregolatori ed antiischemici.

Publications (1)

Publication Number Publication Date
BE1003255A5 true BE1003255A5 (fr) 1992-02-11

Family

ID=11184201

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900822A BE1003255A5 (fr) 1988-08-01 1989-08-01 Acides (rs)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofurannyl)-acetiques et acides 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzo-furannyl)-acetiques et leurs esters mucoregulateurs et anti-ischemiques et procede pour les preparer.

Country Status (15)

Country Link
US (2) US4999350A (fr)
JP (1) JPH0278675A (fr)
KR (1) KR0129526B1 (fr)
CN (1) CN1034574C (fr)
BE (1) BE1003255A5 (fr)
CA (1) CA1324134C (fr)
CH (1) CH679583A5 (fr)
DE (1) DE3925496A1 (fr)
ES (1) ES2014188A6 (fr)
FR (1) FR2634766A1 (fr)
GB (1) GB2221463B (fr)
HK (1) HK48693A (fr)
IT (1) IT1229482B (fr)
SE (1) SE469652B (fr)
SG (1) SG26693G (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231341B (it) * 1989-08-18 1991-11-28 Foscama Biomed Chim Farma 2,3 diidro 5 ossi 4,6,7 trimetilbenzofurani 2 (rs) sostituiti, utili come farmaci antiossidanti con proprieta' mucoregolatrici e antiischemiche.
IT1239946B (it) * 1990-03-12 1993-11-27 Biomedica Foscama Industria Chimicofarmaceutica Procedimento per la sintesi degli acidi 5-acilossi e 5-alcossi-2,3-diidro-4,6,7-trimetil-2-(rs)-benzofuranacetici
US5240956A (en) * 1990-11-07 1993-08-31 Cortech, Inc. Ester inhibitors
EP0550292A1 (fr) * 1992-01-02 1993-07-07 Merrell Dow Pharmaceuticals Inc. Analogues de tocophérol de protection des tissus
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
EP0635009B1 (fr) * 1992-04-06 1997-09-17 Merrell Pharmaceuticals Inc. Nouveaux derives de 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
TW393475B (en) * 1992-10-16 2000-06-11 Chugai Pharmaceutical Co Ltd 4-alkoxyl-2,6-di-t-butyl phenol derivatives
IT1289494B1 (it) * 1996-12-20 1998-10-15 Biomedica Foscana Ind Chimico Acidi 5-idrossi- e 5-acilossi-2,3-diidro-4,6,7-trimetil-2- benzofuranaceti e loro esteri per il trattamento e la prevenzione
IT1320131B1 (it) * 2000-12-21 2003-11-18 Foscama Biomed Chim Farma Uso degli acidi 5-idrossi e 5-acilossi-2,3-diidro-4,6,7-trimetil-2-benzofuranacetici e loro esteri come cicatrizzanti delle lesioni

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165810A2 (fr) * 1984-06-20 1985-12-27 Merck Frosst Canada Inc. Dérivés de benzofuranne et de benzothiophène, leur application pour inhiber la biosynthèse de leucotriène aux mammifères et compositions pharmaceutiques contenant ces dérivés
JPS6388173A (ja) * 1986-09-30 1988-04-19 Kuraray Co Ltd 2,3−ジヒドロベンゾフラン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6065063A (ja) * 1983-09-20 1985-04-13 Matsunaga Kagaku Kogyo Kk 難燃化剤
US4537903A (en) * 1983-10-12 1985-08-27 Merck & Co., Inc. Substituted cinnamyl-2,3-dihydrobenzofuran and analogs useful as anti-inflammatory agents
US4918092A (en) * 1983-12-21 1990-04-17 Merck Frosst Canada, Inc. Leukotriene antagonists
EP0273647B1 (fr) * 1986-12-27 1992-03-11 Takeda Chemical Industries, Ltd. Dérivés de coumaranne, leur préparation et leur utilisation
JP2855340B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 2―置換クマラン誘導体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165810A2 (fr) * 1984-06-20 1985-12-27 Merck Frosst Canada Inc. Dérivés de benzofuranne et de benzothiophène, leur application pour inhiber la biosynthèse de leucotriène aux mammifères et compositions pharmaceutiques contenant ces dérivés
JPS6388173A (ja) * 1986-09-30 1988-04-19 Kuraray Co Ltd 2,3−ジヒドロベンゾフラン誘導体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 110, no. 9, 27 février 1989, page 630, abrégé no. 75294x, Columbus, Ohio, US; & JP-A-63 088 173 (KURARAY CO., LTD) 19-04-1988 *

Also Published As

Publication number Publication date
SE8902603D0 (sv) 1989-07-26
SG26693G (en) 1993-05-21
GB8917515D0 (en) 1989-09-13
DE3925496A1 (de) 1990-02-22
JPH0278675A (ja) 1990-03-19
IT1229482B (it) 1991-09-03
HK48693A (en) 1993-05-27
US5041568A (en) 1991-08-20
SE8902603L (sv) 1990-02-02
KR0129526B1 (ko) 1998-04-09
GB2221463B (en) 1992-03-25
ES2014188A6 (es) 1990-06-16
CN1034574C (zh) 1997-04-16
IT8821603A0 (it) 1988-08-01
KR900003145A (ko) 1990-03-23
FR2634766A1 (fr) 1990-02-02
FR2634766B1 (fr) 1994-08-19
DE3925496C2 (fr) 1992-04-30
US4999350A (en) 1991-03-12
CN1042354A (zh) 1990-05-23
GB2221463A (en) 1990-02-07
CH679583A5 (fr) 1992-03-13
SE469652B (sv) 1993-08-16
CA1324134C (fr) 1993-11-09

Similar Documents

Publication Publication Date Title
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
NO20000413L (no) Karbamyloksyforbindelser som inhiberer leukocytt adhesjon mediert av VLA-4
BE862864A (fr) Procede de preparation d'organopolysiloxanes modifies par des esters d'acide acrylique ou methacrylique, et produits ainsi obtenus
BE1003255A5 (fr) Acides (rs)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofurannyl)-acetiques et acides 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzo-furannyl)-acetiques et leurs esters mucoregulateurs et anti-ischemiques et procede pour les preparer.
DE59007531D1 (de) Verwendung des Wirkstoffs Azelastin zur Bekämpfung von Psoriasis-Erkrankungen.
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
FR2584727B1 (fr) Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
FR2555050B1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
ATE88718T1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
ATE181237T1 (de) Substituierte cyclohexan-derivate zur behandlung von krankheiten
MC1998A1 (fr) Composes pour le traitement des maladies hyperproliferatibes et procede de preparation
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
MC1440A1 (fr) Derives de la pyrrolidine,sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
MA22195A1 (fr) Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux lencotrienes
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
RU94022481A (ru) Способ определения иммуногенной активности биоактивных соединений и состав для его осуществления
DE69621786T2 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
MA22196A1 (fr) Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
BE889699A (fr) Derives amidiques de l'acide p-isobutylphenyl propionique, leur procede de preparation et compositions pharmaceutiques correspondantes
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
MA20150A1 (fr) Derives de l'acide bicyclo (3,2-1) octane carboxylique et leur procede de preparation et leur application therapeutique.
MA22197A1 (fr) Procede de preparation de derives de l'acide benzoique destines au traitement des maladies associees aux leucotrienes
DE69025967T2 (de) Aryl- oder Heteroaryl-1-alkyl-pyrrol-2-carbonsäure-Derivate, zur Behandlung von durch Interleukin-1 hervorgerufenen Erkrankungen

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20050831